Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease	Leptomeningeal Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Uveal Neoplasms, acral lentiginous melanoma, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, eye disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanocytic nevus, melanoma, metastatic melanoma, neoplasm, nervous system disorder, neuroendocrine neoplasm, non-small cell lung carcinoma, ocular cancer, primary melanoma of the central nervous system, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, tumor of meninges, uveal disorder, uveal melanoma	Active, not recruiting	Phase 1	2026-08-19		NCT03025256

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
M.D. Anderson Cancer Center	1145
National Cancer Institute (NCI)	3015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
M D Anderson Cancer Center	Houston	United States	667